Enzyme-Triggered Size-Switchable Nanosystem for Deep Tumor Penetration and Hydrogen Therapy
ACS Applied Materials & Interfaces · 2023-01-11 · 15 (1) · 552-565
DOI: 10.1021/acsami.2c18184 ↗At a glance
Journal article in ACS Applied Materials & Interfaces, published online on 2023-01-03. Written by Yongju He and 8 co-authors. Institution: School of Materials Science and Engineering, Central South University, Changsha, Hunan410083, China. Major MEDLINE topics: Antineoplastic Agents, Nanoparticles. Cited 34 times so far (Crossref); 55 references. Funded by: Central South University, Natural Science Foundation of?Hunan Province, Central University Basic Research Fund of China.
Abstract (original language)
The poor penetration of nanocarriers within tumor dense extracellular matrices (ECM) greatly restricts the access of anticancer drugs to the deep tumor cells, resulting in low therapeutic efficacy. Moreover, the high toxicity of the traditional chemotherapeutics inevitably causes undesirable side effects. Herein, taking the advantages of biosafe H2 and small-sized nanoparticles in diffusion within tumor ECM, we develop a matrix metalloprotease 2 (MMP-2) responsive size-switchable nanoparticle (UAMSN@Gel-PEG) that is composed of ultrasmall amino-modified mesoporous silica nanoparticles (UAMSN) wrapped within a PEG-conjugated gelatin to deliver H2 to the deep part of tumors for effective gas therapy. Ammonia borane (AB) is chosen as the H2 prodrug that can be effectively loaded into UAMSN by hydrogen-bonding adsorption. Gelatin is used as the substrate of MMP-2 to trigger size change and block AB inside UAMSN during blood circulation. PEG is introduced to further increase the particle size and endow the nanoparticle with long blood circulation to achieve effective tumor accumulation via the EPR effect. After accumulation into the tumor site, MMP-2 promptly digests gelatin to expose UAMSN loading AB for deep tumor penetration. Upon stimulation by the acidic tumor microenvironment, AB decomposes into H2 for further intratumor diffusion to achieve effective hydrogen therapy. Consequently, such a simultaneous deep tumor penetration of nanocarriers and H2 results in an evident suppression on tumor growth in a 4T1 tumor-bearing model without any obvious toxicity on normal tissues. Our synthetic nanosystem provides a promising strategy for the development of nanomedicines with enhanced tumor permeability and good biosafety for efficient tumor treatment.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Materials Science and Engineering, Central South University, Changsha, Hunan410083, China.
- Department of Neurology, The Second Xiangya Hospital, Central South University, Changsha, Hunan410011, China.
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan410013, China.
- Institute of Super-Microstructure and Ultrafast Process in Advanced Materials, School of Physics and Electronics, Central South University, Changsha, Hunan410083, China.
ORCID profiles: Yongju He, Songwen Tan, Anqiang Pan, Shuquan Liang, Hui Xu
Funding
- Central South University
- Natural Science Foundation of?Hunan Province
- Central University Basic Research Fund of China
- National Natural Science Foundation of China
Cite
APA
He, Y., Tian, X., Fan, X., Gong, X., Tan, S., Pan, A., Liang, S., Xu, H., & Zhou, F. (2023). Enzyme-Triggered Size-Switchable Nanosystem for Deep Tumor Penetration and Hydrogen Therapy. ACS Applied Materials & Interfaces, 15(1), 552-565. https://doi.org/10.1021/acsami.2c18184
Vancouver
He Y, Tian X, Fan X, Gong X, Tan S, Pan A, et al. Enzyme-Triggered Size-Switchable Nanosystem for Deep Tumor Penetration and Hydrogen Therapy. ACS Applied Materials & Interfaces. 2023;15(1):552-565. doi:10.1021/acsami.2c18184
BibTeX
@article{He2023,
author = {He, Yongju and Tian, Xiangjie and Fan, Xingyu and Gong, Xiyu and Tan, Songwen and Pan, Anqiang and Liang, Shuquan and Xu, Hui and Zhou, Fangfang},
title = {Enzyme-Triggered Size-Switchable Nanosystem for Deep Tumor Penetration and Hydrogen Therapy},
journal = {ACS Applied Materials & Interfaces},
year = {2023},
volume = {15},
number = {1},
pages = {552--565},
doi = {10.1021/acsami.2c18184}
}
EUVIMED